Delivery systems to increase the selectivity of antibiotics in phagocytic cells

被引:163
作者
Briones, Elsa [1 ]
Colino, Clara Isabel [1 ]
Lanao, Jose M. [1 ]
机构
[1] Univ Salamanca, Fac Pharm, Dept Pharm & Pharmaceut Technol, Salamanca 37007, Spain
关键词
delivery systems; antibiotics; phagocytic cells; intracellular infections; selectivity;
D O I
10.1016/j.jconrel.2007.10.027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Many infectious diseases are caused by facultative organisms that are able to survive in phagocytic cells. The intracellular location of these microorganisms protects them from the host defence systems and from some antibiotics with poor penetration into phagocytic cells. One strategy used to improve the penetration of antibiotics into phagocytic cells is the use of carrier systems that deliver these drugs directly to the target cell. Delivery systems such as liposomes, micro/nanoparticles, lipid systems, conjugates, and biological carriers such as erythrocyte ghosts may contribute to increasing the therapeutic efficacy of antibiotics and antifungal agents in the treatment of infections caused by intracellular microorganisms. The main objective of this review is to analyze recent advances and current perspectives in the use of antibiotic delivery systems in the treatment of intracellular infections such as mycobacterial infections, brucellosis, salmonellosis, lysteriosis, fungal infections, visceral leishmaniasis, and HIV (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:210 / 227
页数:18
相关论文
共 210 条
[1]   LIPOSOME TOXICITY IN MOUSE CENTRAL NERVOUS-SYSTEM [J].
ADAMS, DH ;
JOYCE, G ;
RICHARDSON, VJ ;
RYMAN, BE ;
WISNIEWSKI, HM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1977, 31 (02) :173-179
[2]   Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine [J].
Adams, LB ;
Sinha, I ;
Franzblau, SG ;
Krahenbuhl, JL ;
Mehta, RT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1638-1643
[3]   AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience [J].
Adler-Moore, J ;
Proffitt, RT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 :21-30
[4]  
AGATHAT W, 2003, J PHARM PHARM SCI, V6, P67
[5]   Tuftsin-bearing liposomes in treatment of macrophage-based infections [J].
Agrawal, AK ;
Gupta, CM .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (02) :135-146
[6]   Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters [J].
Agrawal, AK ;
Agrawal, A ;
Pal, A ;
Guru, PY ;
Gupta, CM .
JOURNAL OF DRUG TARGETING, 2002, 10 (01) :41-45
[7]   Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae [J].
Ahrén, IL ;
Karlsson, E ;
Forsgren, A ;
Riesbeck, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) :903-906
[8]   Targeting to macrophages:: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages [J].
Ahsan, FL ;
Rivas, IP ;
Khan, MA ;
Suárez, AIT .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :29-40
[9]  
Alonso-Vargas Rocio, 2000, Revista Iberoamericana de Micologia, V17, P90
[10]  
ALVAREZ FE, 1995, ANN CLIN LAB SCI, V25, P283